SYSTEM AND METHOD FOR TRACKING CONSUMER HEALTHCARE BEHAVIOR

• US 20100241459A1
• Filed: 05/03/2010
• Published: 09/23/2010
• Est. Priority Date: 03/30/2005
• Status: Abandoned Application

• Current Assignee: Quality Health Limited (IQVIA Holdings, Inc.)
• Original Assignee: Quality Health Limited (IQVIA Holdings, Inc.)
• Inventors: Rao, Y. Ramprasad
• Application Number:
  US12/772,529
• Publication Number:
  US 20100241459A1
• Time in Patent Office: Days
• US Class Current: 705/3
• CPC Class Codes: G06Q 30/02 Marketing; Price estimation or determination; Fundraising
• CPC Class Codes: G06Q 30/0203 Market surveys; Market polls
• CPC Class Codes: G16H 10/20 for electronic clinical trials or questionnaires
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 40/67 for remote operation

Abstract

A method of tracking healthcare consumer purchase behavior and attitudes, ibncluding recruiting a panel of patients suffering from a medical condition; collecting data regarding attitudes and demographics of said patients; collecting data regarding purchase behavior of said patients; correlating said data regarding attitudes and demographics of said patients to said data regarding purchase behavior of said patients; and making one or more assessments regarding a future marketing strategy.

Claims

1. A method of tracking healthcare consumer purchase behavior and attitudes, comprising:

recruiting a panel of patients suffering from a medical condition;

collecting data regarding attitudes and demographics of said patients;

collecting data regarding purchase behavior of said patients;

correlating said data regarding attitudes and demographics of said patients to said data regarding purchase behavior of said patients; and

making one or more assessments regarding a future marketing strategy.

2. The method of claim 1, wherein the data regarding attitudes and demographics of said patients is collected by means of surveys.

3. The method of claim 1, wherein the correlating is accomplished by employing identifying information.

4. The method of claim 3, wherein the identifying information includes one or more of the panelist'"'"'s name;

the panelist'"'"'s gender;

the panelist'"'"'s date of birth;

the panelist'"'"'s address;

and the panelist'"'"'s telephone number.

5. The method of claim 2, wherein the surveys are conducted at more than one point in time.

6. The method of claim 5, wherein the surveys include personal questions regarding the patient.

7. The method of claim 6, wherein the personal questions relate to one or more of medical conditions;

emotional well-being;

diet;

exercise habits;

finances;

marital status;

family dynamics; and

recreational preferences.

8. The method of claim 1, wherein the data regarding patient purchase behavior includes retail sales records.

9. The method of claim 8, wherein the retail sales records are pharmacy retail sales records.

10. The method of claim 8, wherein the retail sales records are de-identified, whereby specific purchases made by a patient cannot be traced back to the patient.

11. The method of claim 8, wherein the retail sales records are collected at more than one point in time.

12. The method of claim 1, wherein the assessments include determining a future course of action for improving patient compliance and persistence.

13. The method of claim 12, wherein the course of action include creating segmented messages that each address an identified reason for non-compliance.

14. The method of claim 12, wherein the course of action include creating segmented messages that each address an identified reason for non-persistence.

15. The method of claim 2, wherein the surveys contain questions designed to obtain insight into factors affecting the panelist'"'"'s attitude toward a product being studied.

16. The method of claim 15, wherein the factors include one or more of news reports;

advertisements;

word of mouth;

comments from physicians;

comments from pharmacists;

cost, ease of use; and

availability of equivalents.

17. The method of claim 15, wherein the product being studied is a drug therapy.

18. The method of claim 1, wherein said panel is recruited by use of advertisements.

19. The method of claim 18, wherein the advertisements are one of more of television advertisements;

radio advertisements; and

Internet advertisements.

20. The method of claim 18, wherein the advertisements include offerings of incentives.

21. The method of claim 1, wherein the panel is recruited by means of direct solicitation.

22. The method of claim 21, wherein the direct solicitation includes the offering of incentives.

23. The method of claim 2, wherein each patient is asked questions regarding the patient'"'"'s beliefs about the medical condition.

24. The method of claim 2, wherein each patient is asked questions regarding the patient'"'"'s beliefs about treatments available for the medical condition.

25. The method of claim 2, wherein each patient is asked questions regarding the patient'"'"'s specific adherence behavior with respect to a particular treatment.

26. The method of claim 12, wherein the courses of action include segmenting compliant and non-compliant patients.

27. The method of claim 12, wherein the courses of action include segmenting persistent and non-persistent patients.

28. The method of claim 12, wherein the courses of action include developing marketing strategies specifically designed to influence the continued adherence of patients with demographics similar to those patients with the highest tendency to be adherent to a prescribed treatment.

29. The method of claim 26, wherein the segmenting is accomplished by using predictive-scoring modeling techniques to determine the demographics of patients with the highest tendency to be compliant with respect to a prescribed treatment.

30. The method of claim 27, wherein the wherein the segmenting is accomplished by using predictive-scoring modeling techniques to determine the demographics of patients with the highest tendency to be persistent with respect to a prescribed treatment.

31. A system for tracking healthcare consumer purchase behavior and attitudes, comprising one or more processors programmed and configured for:

receiving data regarding attitudes and demographics of a panel of patients suffering from a medical condition;

receiving data regarding purchase behavior of said patients;

correlating said data regarding attitudes and demographics of said patients to said data regarding purchase behavior of said patients; and

making one or more assessments regarding a future marketing strategy.

32. The system of claim 31, wherein the data regarding attitudes and demographics of said patients is collected by means of computerized surveys.

33. The system of claim 32, wherein the surveys are conducted at more than one point in time.

34. The system of claim 31, wherein the data regarding patient purchase behavior includes retail sales records.

35. The system of claim 34, wherein the retail sales records are collected at more than one point in time